Thermo Fisher expands COVID-19 therapies, vaccines

By The Science Advisory Board staff writers

July 20, 2020 -- Thermo Fisher Scientific is expanding the development and production of COVID-19 vaccines, therapies, and additional treatments.

The U.S. Biomedical Advanced Research and Development Authority is providing funding to the company for expanded manufacturing capacity for sterile injectables, which can be used to fill a high volume of vaccine doses. Additionally, the company is assisting with several vaccine programs that are currently under clinical development.

Thermo Fisher is supporting over 200 COVID-19 related projects with an investment of over $800 million. This work has provided expanded capacity for developing new and existing therapies such as antiviral drugs to accelerate development and delivery to the clinic. Moreover, the company's "site to patient" program works to ensure that clinical trial participants have uninterrupted access to life-saving investigational drug shipments without having to visit a clinic.

Thermo Fisher to develop, manufacture next-gen immunotherapy
Thermo Fisher Scientific has formed a strategic partnership with PharmAbcine for the development and manufacturing of PMC-309, a next-generation immune...
Thermo releases spectrometry products for proteomics
Thermo Fisher Scientific has announced an exclusive license agreement with software firm MSAID for intelligent software that uses deep learning facilitated...
Thermo Fisher gets U.S. contract for COVID-19 sample collection
Thermo Fisher Scientific announced that it has received a contract from the U.S. government to provide highly specialized viral transport media for COVID-19...
Thermo Fisher to double viral vector manufacturing capacity
Thermo Fisher Scientific is expanding its viral vector development and manufacturing services with construction of a new commercial manufacturing site...
Thermo Fisher launches SARS-CoV-2 GlobalAccess Sequencing Program
Thermo Fisher Scientific is providing 50 units of its Ion Torrent Genexus system at a subsidized price to support global COVID-19 research as part of...

Copyright © 2020

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter